Aug 5, 2026 05:38PM
Aug 5, 2026 04:05PM
Jul 22, 2026 04:05PM
May 6, 2026 04:07PM
May 6, 2026 04:05PM
Apr 23, 2026 04:05PM
Feb 24, 2026 07:05AM Vir Biotechnology (VIR) PT Raised to $18 at Needham
Feb 23, 2026 05:25PM
Feb 23, 2026 05:15PM
Feb 23, 2026 05:14PM
Feb 23, 2026 05:02PM
Feb 23, 2026 05:02PM
Feb 23, 2026 05:01PM
Feb 23, 2026 05:00PM Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
Feb 9, 2026 04:05PM
Jan 12, 2026 08:07AM
Jan 12, 2026 08:00AM
Nov 5, 2025 04:20PM
Nov 5, 2025 04:05PM
Oct 22, 2025 04:05PM
Aug 6, 2025 04:10PM Vir Biotechnology Inc. (VIR) Misses Q2 EPS by 10c, provides guidance
Aug 6, 2025 04:05PM
Jul 22, 2025 04:05PM
May 7, 2025 04:13PM
May 7, 2025 04:05PM
Apr 30, 2025 04:05PM
Mar 21, 2025 07:10AM
Feb 26, 2025 04:14PM Vir Biotechnology Inc. (VIR) Tops Q4 EPS by 11c
Feb 26, 2025 04:05PM
Feb 12, 2025 04:05PM
Nov 26, 2024 09:30AM
Oct 31, 2024 04:10PM
Oct 31, 2024 04:05PM
Oct 17, 2024 04:30PM
Sep 9, 2024 04:13PM Vir Biotechnology (VIR) Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers
Sep 9, 2024 04:05PM
Sep 4, 2024 08:30AM
Aug 20, 2024 06:45AM
Aug 1, 2024 04:24PM
Aug 1, 2024 04:14PM
Aug 1, 2024 04:02PM
Aug 1, 2024 04:01PM Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers
Jul 18, 2024 04:05PM
May 2, 2024 04:34PM
May 2, 2024 04:05PM
Apr 11, 2024 04:30PM
Mar 22, 2024 07:00AM
Feb 22, 2024 04:08PM
Feb 22, 2024 04:05PM Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 1, 2024 04:05PM

1,217,557 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All